Calreticulin, an ER luminal protein traditionally regarded as a calcium-buffering chaperone of the endoplasmic reticulum35, could be expressed on the tumor cell surface during chemotherapy to induce dendritic cell-mediated phagocytosis of tumor cells, providing a new immunogenic chemotherapy for cancers. This evidence concerns the gene CALR and neoplasm.